Differentiated thyroid carcinoma : treatment and clinical consequences of therapy

Hoftijzer, H.C. (2011)

Doctoral Thesis

The first chapters of this thesis describe the treatment of radioiodine non-avid thyroid carcinoma with the tyrosine kinase inhibitor sorafenib. The remainder of the thesis describes the clinical consequences of the treatment of thyroid carcinoma.

• Differentiated thyroid carcinoma
• Diagnosis
• Treatment
• Thyroid hormone metabolism

• All authors: Hoftijzer, H.C.
• Supervisor: Smit, J.W.A.; Romijn, J.A.
• Co-supervisor: Kleij-Corssmit, E.P.M. van der
• Qualification: Doctor (dr.)
• Awarding Institution: Leiden University Medical Center (LUMC), Leiden University
• Date: 2011-05-12
• ISBN (print): 9789461690326
• Sponsorship: Bayer B.V. Novo Nordisk B.V. Servier Nederland Farma B.V. MSD B.V. Genzyme B.V. AstraZeneca B.V. Ipsen Farmaceutica B.V. Novartis Pharma B.V. J.E. Jurriaanse Stichting